Devapregasan Moodley
Impact in
- Immunology top 10%
- interferon and immune responses
- Immune Cell Function and Interaction
- Immune cells in cancer
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Heat shock proteins research 2
-
- Immune Cell Function and Interaction 3
- Co-authors
- Anil A. Chuturgoon (19 shared papers)Alisa Phulukdaree (14 shared papers)Hideyuki Yoshida (2 shared papers)Jean‐Baptiste Telliez (2 shared papers)Diane Mathis (2 shared papers)Christophe Benoıst (2 shared papers)Sara Mostafavi (2 shared papers)Martin Hegen (2 shared papers)
- Journals
- Gene (3 papers)Cancer Research (3 papers)South African Journal of Science (2 papers)Metabolic Syndrome and Related Disorders (2 papers)Toxicology Letters (2 papers)
- Partner nations
- South AfricaUnited StatesCanada
In The Last Decade
Devapregasan Moodley
29 papers receiving 856 citations
Peers
Comparison fields: 5 of 94
- Immunology 295
- Cancer Research 136
- Geriatrics and Gerontology 28
- Drug Discovery 1
- Oncology 139
Countries citing papers authored by Devapregasan Moodley
This map shows the geographic impact of Devapregasan Moodley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devapregasan Moodley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devapregasan Moodley more than expected).
Fields of papers citing papers by Devapregasan Moodley
This network shows the impact of papers produced by Devapregasan Moodley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devapregasan Moodley. The network helps show where Devapregasan Moodley may publish in the future.
Co-authors
The 25 scholars most cited alongside Devapregasan Moodley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 210 | |
| 2 | 2013 | 104 | |
| 3 | 2013 | 68 | |
| 4 | 2016 | 62 | |
| 5 | 2019 | 60 | |
| 6 | 2014 | 58 | |
| 7 | 2016 | 53 | |
| 8 | 2013 | 33 | |
| 9 | 2011 | 29 | |
| 10 | 2012 | 28 | |
| 11 | 2015 | 24 | |
| 12 | 2015 | 20 | |
| 13 | 2015 | 19 | |
| 14 | 2010 | 15 | |
| 15 | 2016 | 13 | |
| 16 | 2016 | 11 | |
| 17 | 2010 | 10 | |
| 18 | 2015 | 9 | |
| 19 | 2020 | 8 | |
| 20 | 2019 | 8 |
About Devapregasan Moodley
Devapregasan Moodley is a scholar working on Molecular Biology, Immunology, Oncology, Epidemiology and Surgery, having authored 29 papers that have together received 869 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immune Cell Function and Interaction (3 papers), Heat shock proteins research (2 papers), CAR-T cell therapy research (2 papers), Sirtuins and Resveratrol in Medicine (2 papers), NF-κB Signaling Pathways (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Immunology (295 citations), Cancer Research (136 citations), Geriatrics and Gerontology (28 citations), Drug Discovery (1 citation) and Oncology (139 citations). Devapregasan Moodley has collaborated with scholars based in South Africa, United States and Canada. Frequent co-authors include Anil A. Chuturgoon, Alisa Phulukdaree, Hideyuki Yoshida, Jean‐Baptiste Telliez, Diane Mathis, Christophe Benoıst, Sara Mostafavi, Martin Hegen, James D. Clark and Girish M. Mody. Their work appears in journals such as Gene, Cancer Research, South African Journal of Science, Metabolic Syndrome and Related Disorders and Toxicology Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.